Suven Life Sciences announces first patient randomized in Phase-2b clinical trial of Ropanicant
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
Godavari Biorefineries receives patent from CNIPA
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Capricor’s BLA for Deramiocel received Priority Review in March 2025
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
India’s nutraceutical industry is expected to reach over US$ 22 billion in 2025
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Celecoxib is a nonsteroidal anti-inflammatory drug
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
Subscribe To Our Newsletter & Stay Updated